Herbalife has agreed to acquire certain assets from UK-based personalised supplements business Bioniq, in a move the company says will expand its ability to deliver data-led nutrition products at scale through its distributor network.
The transaction is expected to close in the second quarter of 2026, subject to customary closing conditions and regulatory approvals. Herbalife said the $55 million purchase price will be paid over five years, including an initial $10 million payment at closing, with a further potential $95 million in contingent payments tied to future performance.
The deal builds on Herbalife’s earlier acquisitions of Pro2col and Link BioSciences, and further signals the company’s effort to position itself as a technology-enabled, data-driven health and wellness platform. Bioniq develops personalised supplement formulas using what Herbalife describes as a patented personalisation engine, individual health data, and a proprietary biomarker database. Its products are marketed to both mainstream wellness users and elite athletes, including Cristiano Ronaldo.
Herbalife Chief Executive Officer Stephan Gratziani said: “The future of health and wellness is becoming more personalised and informed by data. By combining Bioniq’s personalised supplement technology with Pro2col and the power of our global distributor network, we are expanding our ability to deliver personalised wellness at global scale.”
Vadim Fedotov, Founder and President of Bioniq, said: “I founded Bioniq in 2019 with a vision to help people optimise their wellbeing through a science-driven approach to nutrition that incorporates biomarker and lifestyle data. I am excited to join Herbalife with its global distributor network and commitment to advancing wellness at scale.” Ronaldo, a Bioniq shareholder and long-time Herbalife partner, also backed the transaction, saying personalised nutrition and biometrics had been central to his performance throughout his career.
As part of the deal, Herbalife has also secured a call option to acquire Bioniq LAB, a separate platform focused on small molecules and peptides. The company said Bioniq products are expected to be offered later this year through independent Herbalife distributors in selected countries in Europe and the United States, with additional markets to follow.
